360 High-Risk Vulnerability Immunization Tool V2.0 vs Sec1 Threat Vision: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Sec1 Threat Vision: AI-driven tool that predicts software package vulnerabilities 90 days ahead. built by Sec1. Core capabilities include 90-day vulnerability forecast using AI/ML algorithms, Historical vulnerability data analysis from Maven, npm, and PyPI, Multi-ecosystem package coverage (Java, Node.js, Python)..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Sec1 Threat Vision differentiates with 90-day vulnerability forecast using AI/ML algorithms, Historical vulnerability data analysis from Maven, npm, and PyPI, Multi-ecosystem package coverage (Java, Node.js, Python).

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Sec1 Threat Vision is developed by Sec1. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Sec1 Threat Vision serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.